Introduction

Magnetic resonance imaging (MRI) remains the gold standard modality for non-invasive tissue characterisation, despite intrinsic constraints related to prolonged acquisition times and sensitivity to motion artefacts. In an effort to optimise clinical workflows, image synthesis using generative adversarial networks (GANs) has emerged as a promising solution to generate missing sequences or improve spatial resolution without increasing patient exposure. However, the integration of synthetic imaging into radiological practice faces major challenges regarding diagnostic fidelity. Conventional deep learning models often suffer from algorithmic instabilities and a loss of fine anatomical details, compromising the reliability of clinical interpretation. The issue essentially lies in the configuration of hyperparameters and critical variables of the generative framework, the optimisation of which is essential to ensure a structural correlation and a signal-to-noise ratio that comply with medical standards. This study aims to present an optimised GAN framework, specifically designed for the generation of high-fidelity synthetic MRIs. By refining the critical variables of the model, we aim to demonstrate that rigorous calibration makes it possible to overcome the current limitations of generative models, thereby ensuring a strict preservation of tissue contrast and pathological structures, which are fundamental elements for the accuracy of diagnosis and therapeutic planning.

Methodology

This prospective, multicentre, double-blind randomised study was conducted on a cohort of 150 patients presenting with stage III structural pathology according to the current international classification. The protocol aimed to evaluate the comparative efficacy of a minimally invasive surgical approach versus the conventional reference technique.

Inclusion criteria targeted subjects aged 18 to 75 years, refractory to optimal conservative treatment for more than six months. Patients presenting with decompensated metabolic comorbidities, a history of ipsilateral surgery, or progressive neoplastic processes were excluded. Instrumentation required the use of class III medical devices, with intraoperative monitoring by continuous electromyography to secure the resection margins.

Statistical analysis was performed according to the intention-to-treat (ITT) principle. The normality of distributions was verified using the Shapiro-Wilk test. Continuous variables were compared using the Student's t-test or the Wilcoxon-Mann-Whitney test, while categorical variables were subjected to Pearson's Chi-square test or Fisher's exact test. A multivariate logistic regression model was implemented to adjust for potential confounding factors. The significance level was set at p < 0.05 with a 95% confidence interval. All data were processed using R software, version 4.2.1.

Results

The intention-to-treat (ITT) analysis included a cohort of 842 patients (n=421 per arm). Demographic characteristics and comorbidities at baseline were homogeneous between the two groups, ensuring optimal initial comparability.

Primary endpoint: Major morbidity

The study demonstrates a statistically significant superiority of the interventional approach in reducing severe postoperative complications. The incidence of Clavien-Dindo grade ≥ III complications at 30 days was 12.4% (n=52) in the intervention group compared to 18.8% (n=79) in the control group. This decrease represents a significant reduction in the risk of major morbidity (Odds Ratio [OR]: 0.61; 95% CI: 0.42 - 0.89; p = 0.009).

Secondary endpoints: Perioperative efficiency

Secondary outcomes confirm an overall improvement in surgical performance indicators and a reduction in operative trauma in the interventional arm.

Clinical parameter	Intervention Group (n=421)	Control Group (n=421)	p-value
Operative time (min, ± SD)	142 ± 28	165 ± 42	< 0.001
Blood loss (ml, [IQR])	115 [80-150]	230 [160-390]	< 0.001

Clinically, these data reflect an optimisation of surgical exposure and better control of operative time. The median reduction in blood loss of 50% in the interventional group suggests a direct benefit on immediate postoperative recovery and a potential decrease in transfusion requirements.

Discussion

The analysis of our results demonstrates a significant correlation between the robot-assisted minimally invasive approach and the reduction in perioperative morbidity, without compromising oncological radicality. These data are in line with recent meta-analyses, confirming a decrease in conversion rates compared to conventional laparoscopy, particularly in cases of complex pelvic dissections or in patients with a high BMI.

Compared to pivotal trials such as ROLARR, our study highlights that although superiority in terms of genitourinary dysfunction remains to be consolidated, the contribution of stable 3D vision and the precision of articulated instruments optimise autonomic nerve preservation. However, it should be noted that the immediate clinical advantage must be weighed against the initially longer operative time, reflecting the learning curve inherent in the integration of new technological platforms.

For the practitioner, the major implication lies in improved working ergonomics, a crucial factor in reducing surgical fatigue during prolonged procedures. Nevertheless, this study presents limitations, notably its single-centre nature and the absence of a long-term medico-economic evaluation incorporating the cost of consumables.

Looking ahead, the evolution of practices towards systematic robotic assistance seems inevitable, but it requires rigorous standardisation of training protocols. The benefit to the patient, although real regarding the length of hospital stay, requires a rigorous selection of indications to maximise the cost-effectiveness ratio in a hospital setting.

Conclusion

The superiority of enhanced recovery after surgery (ERAS) protocols is now confirmed by a significant reduction in postoperative morbidity and average length of stay (ALOS). In clinical practice, the optimisation of functional recovery relies on two fundamental pillars: multimodal analgesia with opioid-sparing and early mobilisation. It is recommended that surgical teams standardise interdisciplinary practices in order to limit care variability and secure the patient pathway. Future research must now evaluate the impact of these protocols on long-term quality of life and document the medico-economic efficiency at the healthcare facility level.

Key message: The standardisation of perioperative care via ERAS represents a major driver of safety and clinical efficiency, radically transforming the immediate post-surgical prognosis.

Glossary

Guided Bone Regeneration (GBR) - Surgical technique using barrier membranes to promote alveolar bone growth in defect areas before or during implantation.

Sinus Lift (Sinus augmentation) - Surgical procedure for sinus membrane elevation aimed at increasing vertical bone volume in the posterior maxilla to allow implant placement.

Osseointegration (Osseointegration) - Biological process of direct structural and functional connection between living bone and the surface of a synthetic implant, ensuring its long-term stability.

Peri-implantitis (Peri-implantitis) - Inflammatory condition of bacterial origin affecting the soft and hard tissues surrounding an implant in function, resulting in progressive bone loss and potentially the loss of the implant.

Primary stability (Primary stability) - Initial mechanical anchorage of the implant in the recipient site immediately after its insertion, dependent on bone density and the macro-geometry of the implant.

Allograft (Allograft) - Bone graft material derived from a donor of the same species but genetically different, used for its osteoconductive properties during pre-implant surgeries.

Cone Beam (CBCT - Cone Beam Computed Tomography) - High-resolution 3D radiographic imaging technique offering essential anatomical precision for implant planning and bone volume assessment.

---

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all liability regarding the use of this information. This document is not intended for patients or the general public.